Related Topics
     

    Roussel: News Releases & Feature Stories

     
    03/27/2014
    Can adult cancer drugs beat a childhood brain tumor?

    Children with an aggressive form of the most common childhood brain tumor, medulloblastoma, face a tough prognosis. Effective treatments are limited, and long-term survival is poor. But new hope may be offered by a discovery from St. Jude Children’s Research Hospital involving a pair of drugs used to treat adult cancers.

     
     
    03/27/2014
    Adult cancer drugs show promise against an aggressive childhood brain tumor

    A St. Jude Children’s Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial. (Martine Roussel, PhD)

     
     
    04/19/2011
    Martine Roussel, Ph.D., honored as 2011 fellow of the American Academy of Arts and Sciences

    Martine Roussel, Ph.D., of St. Jude Children’s Research Hospital, has been named to the 2011 class of new Fellows and Foreign Honorary Members of the American Academy of Arts and Sciences.

     
     
    04/07/2009
    Tiny genetic materials identified as key players in causing medulloblastoma

    Researchers at St. Jude have demonstrated for the first time that tiny molecules called microRNAs participate in the initiation and progression of one form of human medulloblastoma, the most common malignant brain cancer in children.

     
     
    09/15/2008
    Making tumor cells disappear

    Stopping brain tumor cells from growing sounds like a dream. Turning those cells into normal brain cells sounds like a fantasy. But scientists at St. Jude Children’s Research Hospital are in the process of turning fantasy into reality.

     
     
    12/12/2005
    Genes team up to suppress brain tumor

    The Ink4c and Ptch1 genes collaborate to suppress the development of the brain tumor medulloblastoma.

     
     
    05/20/2003
    St. Jude researchers help link progressive hearing loss to Ink4d gene

    Researchers may have found a link between progressive hearing loss and a gene called p19Ink4d (Ink4d), according to the results of a study co-authored by St. Jude investigators, that measured hearing loss in mice lacking that gene.

     
     
    05/01/2003
    Ears can't hear when special sensory cells don't stay "quiet"

    Researchers may have found a link between progressive hearing loss and a gene called p19Ink4d (Ink4d)